Status:
COMPLETED
Feasibility Trial of a Stakeholder-enhanced Lay-navigator-delivered Intervention (ImPart-Multi)
Lead Sponsor:
University of Alabama at Birmingham
Conditions:
Kidney Diseases
Cardiometabolic Risk Factors
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
We seek to explore the feasibility and acceptability of participation in a decision-support training program led by lay navigators. ImPart-Multi, an education-telehealth-based, is designed to empower ...
Detailed Description
Black people with chronic kidney disease and uncontrolled high blood pressure face a higher risk of developing severe cardiovascular disease and face an additional risk of their kidney disease getting...
Eligibility Criteria
Inclusion
- Patients
- Electronic medical record (EMR) documented diagnosis of stage 3 or 4 CKD (2 estimated glomerular filtration rate \[eGFR\] between 45-15 within 90 days); and concurrent cardiometabolic disease (hypertension and/or diabetes)
- Ability to speak and read English and complete baseline questionnaires;
- Patients must have a care partner enrolled in the study - the team will assist any patient in identifying a care partner, if interested.
- Care partner
- Age ≥18; 2) Self-endorsing or identified by the patient as "a relative, friend, or partner that has a close relationship with you and who assists you with your medical decisions and who may or may not live in the same residence as you and who is not paid for their help";
- Ability to speak and read English and complete baseline questionnaires;
- Care partners must have an enrolled patient.
Exclusion
- Patients
- Receiving hospice;
- Receiving dialysis;
- Medical record documentation of active unmedicated severe mental illness, moderate-severe dementia, suicidal ideation, uncorrected hearing loss, and active substance abuse.
Key Trial Info
Start Date :
March 20 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 25 2025
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT06067009
Start Date
March 20 2024
End Date
February 25 2025
Last Update
March 7 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Alabama at Birmingham
Birmingham, Alabama, United States, 35294-0001